These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 5410625)

  • 1. Pyrrolopyrimidine nucleosides. V. A study on the relative chemical reactivity of the 5-cyano group of the nucleoside antibiotic toyocamycin and desaminotoyocamycin. The synthesis of analogs of sangivamycin.
    Hinshaw BC; Gerster JF; Robins RK; Townsend LB
    J Org Chem; 1970 Jan; 35(1):236-41. PubMed ID: 5410625
    [No Abstract]   [Full Text] [Related]  

  • 2. Nucleoside antibiotics. VI. Biosynthesis of the pyrrolopyrimidine nucleoside antibiotic toyocamycin by Streptomyces rimosus.
    Uematsu T; Suhadolnik RJ
    Biochemistry; 1970 Mar; 9(5):1260-6. PubMed ID: 5418715
    [No Abstract]   [Full Text] [Related]  

  • 3. Pyrrolopyrimidine nucleosides. Part X. Synthesis of certain 4,5-disubstituted 7-(beta-D-ribofuranosyl)pyrrolo[2,3-d]pyrimidines related to toyocamycin and sangivamycin.
    Hinshaw BC; Leonoudakis O; Schram KH; Townsend LB
    J Chem Soc Perkin 1; 1975; (13):1248-53. PubMed ID: 1171884
    [No Abstract]   [Full Text] [Related]  

  • 4. Pyrrolopyrimidine nucleosides. 3. The total synthesis of toyocamycin, sangivamycin, tubercidin, and related derivatives.
    Tolman RL; Robins RK; Townsend LB
    J Am Chem Soc; 1969 Apr; 91(8):2102-8. PubMed ID: 5805382
    [No Abstract]   [Full Text] [Related]  

  • 5. Deciphering deazapurine biosynthesis: pathway for pyrrolopyrimidine nucleosides toyocamycin and sangivamycin.
    McCarty RM; Bandarian V
    Chem Biol; 2008 Aug; 15(8):790-8. PubMed ID: 18721750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, cytotoxicity, and antiviral activity of certain 7-[(2-hydroxyethoxy)methyl]pyrrolo[2,3-d]pyrimidine nucleosides related to toyocamycin and sangivamycin.
    Gupta PK; Nassiri MR; Coleman LA; Wotring LL; Drach JC; Townsend LB
    J Med Chem; 1989 Jul; 32(7):1420-5. PubMed ID: 2500527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyrrolo[2,3-d]pyrimidine nucleoside antibiotics. Total synthesis and structure of toyocamycin, unamycin B, vengicide, antibiotic E-212, and Sangivamycin (BA-90912).
    Tolman RL; Robins RK; Townsend LB
    J Am Chem Soc; 1968 Jan; 90(2):524-6. PubMed ID: 5634627
    [No Abstract]   [Full Text] [Related]  

  • 8. SYNTHESIS OF PYRROLO(2,3-D)PYRIMIDINES. THE AGLYCONE OF TOYOCAMYCIN.
    TAYLOR EC; HENDESS RW
    J Am Chem Soc; 1965 May; 87():1995-2003. PubMed ID: 14290275
    [No Abstract]   [Full Text] [Related]  

  • 9. Synthesis of non-nucleoside analogs of toyocamycin, sangivamycin, and ++thiosangivamycin: influence of various 7-substituents on antiviral activity.
    Renau TE; Wotring LL; Drach JC; Townsend LB
    J Med Chem; 1996 Feb; 39(4):873-80. PubMed ID: 8632411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, cytotoxicity, and antiviral activity of some acyclic analogues of the pyrrolo[2,3-d]pyrimidine nucleoside antibiotics tubercidin, toyocamycin, and sangivamycin.
    Gupta PK; Daunert S; Nassiri MR; Wotring LL; Drach JC; Townsend LB
    J Med Chem; 1989 Feb; 32(2):402-8. PubMed ID: 2913300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyrazolopyrimidine nucleosides. Part I. Synthesis of pyrazolopyrimidine nucleosides related to the nucleoside antibiotic tubercidin.
    Revankar GR; Townsend LB
    J Chem Soc Perkin 1; 1971; 13():2440-2. PubMed ID: 5166603
    [No Abstract]   [Full Text] [Related]  

  • 12. [Chemical synthesis of nucleosides. 1].
    Mizuno Y
    Tanpakushitsu Kakusan Koso; 1968; ():Suppl:3-64. PubMed ID: 4882546
    [No Abstract]   [Full Text] [Related]  

  • 13. Synthesis and biological activity of 4'-thio analogs of the antibiotic toyocamycin.
    Bobek M; Whistler RL; Bloch AA
    J Med Chem; 1972 Feb; 15(2):168-71. PubMed ID: 4621465
    [No Abstract]   [Full Text] [Related]  

  • 14. Arabinofuranosylpyrrolo[2,3-d]pyrimidines as potential agents for human cytomegalovirus infections.
    Krawczyk SH; Bernier-Rodriguez M; Nassiri MR; Kern ER; Wotring LL; Drach JC; Townsend LB
    J Med Chem; 1990 Dec; 33(12):3160-9. PubMed ID: 2175356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleosides. LXXII. Synthetic studies on nucleoside antibiotics. 7. An improved synthesis of C-substance.
    Watanabe KA; Wempen IM; Fox JJ
    Carbohydr Res; 1972 Jan; 21(1):148-53. PubMed ID: 5044137
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of the cellular and RNA-dependent effects of sangivamycin and toyocamycin in human colon carcinoma cells.
    Cohen MB; Glazer RI
    Mol Pharmacol; 1985 Mar; 27(3):349-55. PubMed ID: 2579317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of non-nucleoside analogs of toyocamycin, sangivamycin, and thiosangivamycin: the effect of certain 4- and 4,6-substituents on the antiviral activity of pyrrolo[2,3-d]pyrimidines.
    Renau TE; Kennedy C; Ptak RG; Breitenbach JM; Drach JC; Townsend LB
    J Med Chem; 1996 Aug; 39(18):3470-6. PubMed ID: 8784444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies directed towards the total syntheses of the nucleoside antibiotics, gougerotin and blasticidin S.
    Fox JJ; Watanabe KA
    Pure Appl Chem; 1971; 28(4):475-87. PubMed ID: 5144403
    [No Abstract]   [Full Text] [Related]  

  • 19. Relationship between cytotoxicity and conversion of thiosangivamycin analogs to toyocamycin analogs in cell culture medium.
    Renau TE; Lee JS; Kim H; Young CG; Wotring LL; Townsend LB; Drach JC
    Biochem Pharmacol; 1994 Aug; 48(4):801-7. PubMed ID: 8080454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrochemical study of the reduction of toyocamycin and sangivamycin in aqueous media.
    Bojarska E; Pawlicki K; Czochralska B
    Acta Biochim Pol; 1987; 34(2):135-44. PubMed ID: 3673437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.